Table 1.

Associations between the relative abundance of gut microbiota phyla and blood immune markers in cases of pediatric multiple sclerosis (MS) and control children [18]

Select findings only shown; further details have been published elsewhere [18]

DMD disease-modifying drugs (alternative name, used interchangeably: IMD; immunomodulatory drugs)

*p < 0.05; **p < 0.01